| Sandu Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524703 |
NSE Symbol : - |
P/E(TTM) : 37.10 |
|
ISIN Demat : INE751D01014 |
Div & Yield% : 1.42 |
EPS(TTM) : 1.52 |
|
Book Value(₹) : 42.29 |
Market Cap(₹Cr) : 54.48 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 17.70 | 17.05 | 15.60 | 17.43 | 16.61 | 17.66 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 17.70 | 17.05 | 15.60 | 17.43 | 16.61 | 17.66 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.03 | 0.04 | 0.31 | 0.03 | 0.09 | 0.00 |
| Total Income | 17.73 | 17.09 | 15.90 | 17.46 | 16.69 | 17.66 |
| Total Expenditure | 16.79 | 16.64 | 14.99 | 16.92 | 15.78 | 17.30 |
| PBIDT | 0.95 | 0.45 | 0.91 | 0.54 | 0.91 | 0.36 |
| Interest | 0.03 | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 |
| PBDT | 0.92 | 0.43 | 0.90 | 0.52 | 0.90 | 0.33 |
| Depreciation | 0.17 | 0.16 | 0.19 | 0.14 | 0.13 | 0.12 |
| Tax | 0.21 | 0.08 | 0.21 | 0.11 | 0.21 | 0.06 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.03 | 0.03 | -0.09 | 0.06 | 0.00 | 0.04 |
| Reported Profit After Tax | 0.50 | 0.17 | 0.59 | 0.21 | 0.55 | 0.11 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.50 | 0.17 | 0.59 | 0.21 | 0.55 | 0.11 |
| EPS (Unit Curr.) | 0.52 | 0.17 | 0.50 | 0.21 | 0.57 | 0.11 |
| EPS (Adj) (Unit Curr.) | 0.52 | 0.17 | 0.50 | 0.21 | 0.57 | 0.11 |
| Calculated EPS (Unit Curr.) | 0.52 | 0.17 | 0.61 | 0.21 | 0.57 | 0.11 |
| Calculated EPS (Adj) (Unit Curr.) | 0.52 | 0.17 | 0.61 | 0.21 | 0.57 | 0.11 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.07 | 0.69 | 2.45 | 0.86 | 2.28 | 0.45 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.07 | 0.69 | 2.45 | 0.86 | 2.28 | 0.45 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 9.66 | 9.66 | 9.66 | 9.66 | 9.66 | 9.66 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 5.37 | 2.64 | 5.83 | 3.10 | 5.48 | 2.04 |
| PBDTM(%) | 5.20 | 2.52 | 5.77 | 2.98 | 5.42 | 1.87 |
| PATM(%) | 2.82 | 1.00 | 3.78 | 1.20 | 3.31 | 0.62 |